Renagel, a new drug to lower serum phosphorus in patients with end-stage renal disease

January 1999

You'll see Renagel, a new drug to lower serum phosphorus in patients with end-stage renal disease.

Renagel (sevelamer) is a polymer that binds and removes phosphates from the GI tract.

It works as well as calcium acetate (PhosLo)...with a lower risk of hypercalcemia and less constipation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote